December 16, 2014
FDA, Joint Commission cite safety concerns with power morcellation
Reports about problems associated with power morcellation in gynecologic surgery led to safety warnings in November 2014 by the Food and Drug Administration (FDA) and the Joint Commission.
Free Daily News
- Celebrate National Nurses Week with exclusive perks, learning opportunities, well-earned appreciation
- Preadmission clinics drive better surgical outcomes, lower costs, fewer cancellations
- Healthcare employment up in April, but overall job market raises concerns
- Take the OR Manager Career/Salary Survey, help shape the future of perioperative leadership
- Virtual care, tech-enabled roles reshape nursing as leaders diverge on care redesign priorities
- As healthcare faces skyrocketing cyberattacks, surgeons are urged to lead frontline defense
- Study shows WHO surgical checklist boosts safety, but compliance gaps risk patient outcomes
- Kentucky Derby, SPD race: Leadership lessons energized SPD professionals at HSPA 2025
- Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy
- Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement